Improving Outcomes in Pancreatic Cancer With Perioperative mFOLFIRINOX

Video

Davendra Sohal, MD, MPH, Department of Hematology and Medical Oncology, Cleveland Clinic, discusses the need for an ongoing study exploring mFOLFIRINOX versus gemcitabine and nab-paclitaxel (Abraxane) in patients with resectable pancreatic adenocarcinoma.

Related Videos
Experts on GI cancer
Experts on GI cancer
Experts on CRC
Related Content